(DN), a leading cause of end-stage renal disease (1, 2), appears to be multi-factorial. Several epidemiological (3, 4) and familial studies (4) (5) (6) have suggested that genetic susceptibility plays an important role in the development and progression of DN.
Nuclear factor-κB (NF-κB), a transcription factor widely distributed in most cell types, including renal cells (7), can be activated by various molecules, such as high glucose, and cytokines (8, 9) . High glucose is the main determinant of the development and progression of DN, and some studies have demonstrated that high glucose levels can rapidly activate NF-κB in renal cells (10) (11) (12) . Therefore, high glucose-induced NF-κB activation may be involved in DN.
The SUMO4 gene, encoding small ubiquitin-like modifier 4, is a posttranscriptional modifier, recently identified as a novel member of the SUMO family (13, 14) . Additionally, SUMO expression has been found to be mainly expressed in the kidneys and immune system (14) . SUMO4 can modify immune response through the putative substrate, inhibitor
IκBα, a suppressor of NF-κB, and then regulate the activation of NF-κB (13) . A common SNP encoding a methionine-to-valine substitution at codon 55 (M55V) has recently been identified (13, 14) . This M55V substitution can result in higher NF-κB transcriptional activity and greater expression of interleukin 12B (13) .
These findings prompted us to investigate the association of SUMO4 M55V variant with the severity of DN in type 2 diabetic patients. Genotyping. Genomic DNA was extracted from peripheral blood samples. SUMO4 annealing/extension at 60°C for 1 minute.
RESEARCH DESIGN AND METHODS
Data were displayed using Sequence Detection System (Applied Biosystems).
Statistical analysis. All data were presented as means ± standard deviation (SD).
Statistical analysis was performed using It is now firmly established that NF-κB is involved in renal diseases (7) . Similarly, NF-κB was also reported to play an important role in the development of diabetic nephropathy (7) (8) (9) (10) (11) (12) . High glucose is known to be able to rapidly activate NF-κB and cytokines in renal cells (7) (8) (9) in control subjects, and 39%, 49 %, and 12%
in patients with type 1 diabetes (13, 20, 21) .
In this study, the frequencies of SUMO4 AA, GA and GG in our type 2 diabetes were 48%, 44% and 8%, respectively, similar to the above−mentioned studies in Asia (13, 20, 21) , but different from Caucasian (13, 22) .
Therefore, our study has some limitations.
The sample size was small and the validity to extrapolate the association of SUMO4 gene variant and the severity of diabetic nephropathy to other ethic populations requires further confirmation.
In conclusion, this study indicates that M55V polymorphism of SUMO4 gene is associated with kidney dysfunction in Taiwanese patients with type 2 diabetes.
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